Investors
Invest in the Future of Bionics
MediVVarse is bridging the affordability gap in prosthetics with deep tech and AI.
The Market Opportunity
India has a massive amputee population, but imported bionic hands cost upwards of $--, making them completely inaccessible.
We are capturing this untapped market by delivering functional EMG prosthetics at 90% lower cost than imported devices.
SAKSHAM Differentiation
- ✓ Superior EMG accuracy through AI
- ✓ Disruptive price point for LMICs
- ✓ Robust CNC titanium core
- ✓ Indigenous manufacturing
Traction & Validation
IIT Ropar
Incubated at TBIF
TRL-5 Reached
Technology Validated
Patent Filed
IP Protection Secured
